Universal CLL1 CAR-T

CAR-T cell therapy targeting CLL1 (CLEC12A) antigen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Universal CLL1 CAR-T, covering 2026-02-25 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on the Safety, Efficacy and Pharmacokinetics of Universal CLL1 Chimeric Antigen Receptor T-Cell in Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]

See pricing